Gilead’s Remdesivir, the Drug that Could Treat Covid-19

Gilead’s Remdesivir, the Drug that Could Treat Covid-19

  • Af
  • Episode
      182
  • Published
      1. maj 2020
  • Forlag
0 Anmeldelser
0
Episode
182 of 1787
Længde
37M
Sprog
Engelsk
Format
Kategori
Økonomi & Business

Gilead CEO Daniel O’Day shares details of Remdesivir’s two positive trials against Covid-19. He explains collaboration among global drugmakers, the process of finding a treatment for coronavirus, and worldwide, equitable distribution of the drug once it’s developed. CNBC’s Senior Health Science Reporter Meg Tirrell traces the history of Remdesivir, as well as the world’s response to pandemics in the past. In a conversation exclusive to Squawk Pod, Tirrell tracks the drugmakers still in the race for a Covid vaccine and treatment, and she explains covering the pandemic accurately amid rapidly evolving headlines.

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.


Lyt når som helst, hvor som helst

Nyd den ubegrænsede adgang til tusindvis af spændende e- og lydbøger - helt gratis

  • Lyt og læs så meget du har lyst til
  • Opdag et kæmpe bibliotek fyldt med fortællinger
  • Eksklusive titler + Mofibo Originals
  • Opsig når som helst
Prøv nu
DK - Details page - Device banner - 894x1036
Cover for Gilead’s Remdesivir, the Drug that Could Treat Covid-19

Other podcasts you might like ...